Mosquirix: World’s first malaria vaccine approved by WHO
The world’s first malaria vaccine RTS, S was also known by the brand name Mosquirix has been approved by the World Health Organisation (WHO). The mosquito-borne disease kills more than 400,000 people a year, mostly African children. The Mosquirix vaccine is developed by British drugmaker GlaxoSmithKline.
Bharat Biotech is the global technology transfer recipient from GlaxoSmithKline (GSK) that has spent over 30 years developing and testing the world’s first malaria vaccine.
A dedicated facility is being constructed at Bhubaneshwar for the manufacturing of the malaria vaccine.
The process of technology transfer has already started. Once things are in place, Bharat Biotech will have to take regulatory approvals from the drug regulator in India to start manufacturing it and will have to get pre-qualification approval from the WHO.